Evaluation of peroxisome proliferator-activated receptor agonists on interleukin-5-induced eosinophil differentiation

Peroxisome proliferator-activated receptor (PPAR) agonists have been suggested as novel therapeutics for the treatment of inflammatory lung disease, such as allergic asthma. Treatment with PPAR agonists has been shown to inhibit airway eosinophilia in murine models of allergic asthma, which can occu...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Smith, Steven G, Hill, Mike, Oliveria, John-Paul, Watson, Brittany M, Baatjes, Adrian J, Dua, Benny, Howie, Karen, Campbell, Heather, Watson, Rick M, Sehmi, Roma, Gauvreau, Gail M
Format: Artigo
Sprache:Inglês
Veröffentlicht: Blackwell Science Inc 2014
Schlagworte:
Original Articles
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4080964/
https://ncbi.nlm.nih.gov/pubmed/24628018
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/imm.12280
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge